SDS Rx Appoints David Emison as President to Drive Growth
Portfolio - People | Jan 31, 2025 | HCI Equity Partner
SDS Rx, a leader in last-mile healthcare logistics and backed by HCI Equity Partners, has announced the appointment of David W. Emison as President. In this newly formed role, Emison will be responsible for driving innovation and growth, reporting directly to CEO Drew Kronick. Emison's strategic vision and deep industry expertise are expected to enhance SDS Rx's position in the healthcare logistics sector. The move underscores a commitment to customer service excellence and a focus on expanding SDS Rx's national footprint. As President, Emison will lead the company’s strategic growth initiatives and foster transformative solutions that meet and exceed customer expectations. His leadership will propel the firm’s continued expansion and reinforce its status as a trusted partner for healthcare delivery services.
Sectors
- Healthcare Logistics
- Private Equity
Geography
- United States – SDS Rx operates within the United States and plans to expand its national footprint under new leadership.
Industry
- Healthcare Logistics – SDS Rx operates in the healthcare logistics sector, providing last-mile delivery solutions crucial for healthcare services.
- Private Equity – HCI Equity Partners is involved in private equity, investing in companies like SDS Rx to drive growth and strategic initiatives.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| SDS Rx | Target Company | Company | A leader in last-mile healthcare logistics, focused on expanding its services within the healthcare industry. |
| HCI Equity Partners | PE Firm | Company | The private equity firm backing SDS Rx, supporting its growth and strategic initiatives. |
| David W. Emison | President | Person | Appointed as President of SDS Rx to lead its growth and innovation strategies. |
| Drew Kronick | CEO | Person | Chief Executive Officer of SDS Rx, overseeing the company’s operations and strategic direction. |